| [1] |
Cardinale D, Colombo A, Lamantia G，et al.Cardio-oncology：a new medical issue[J]．Ecancermedicalscience，2008(2):126.
|
| [2] |
Zamorano JL, Lancellotti P, Rodriguez MD, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines：the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)[J]．Eur Heart J，2016，37(36):2768-2801.
|
| [3] |
Lenihan DJ, Cardinale D, Cipolla CM. The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society[J]．Prog Cardiovasc Dis，2010，53(2):88-93.
|
| [4] |
夏云龙，张运．萌芽中的肿瘤心脏病学：机遇与挑战[J]．中华心血管病杂志，2017，45(3):182-185.
|
| [5] |
Jerusalem G, Moonen M, Freres P，et al.The european association of cardiovascular imaging/heart failure association cardiac oncology toxicity registry：long-term benefits for breast cancer treatment[J]．Future Oncol，2015，11(20):2791-2794.
|
| [6] |
Curigliano G, Cardinale D, Suter T，et al.Cardiovascular toxicity induced by chemotherapy，targeted agents and radiotherapy：ESMO Clinical Practice Guidelines[J]．Ann Oncol，2012，23(Suppl 7):i155-i166.
|
| [7] |
吕海辰，刘莹，刘基巍，等．浅谈肿瘤心脏病学临床实践中的若干问题[J]．中国实用内科杂志，2018，38(7):589-591.
|
| [8] |
袁丽君．肿瘤心脏病学：超声医学面临的机遇与挑战[J/CD]．中华医学超声杂志(电子版)，2018，15(6):401-403.
|
| [9] |
党喜同，黄文俊，曾晓荣，等．肿瘤心脏病学的生理学基础[J]．生理科学进展，2018，49(5):337-342.
|
| [10] |
钟久昌．肿瘤心脏病学科的过去、现在与将来——机遇和挑战[J]．药学进展，2010，42(7):481-482.
|
| [11] |
邵群，张志仁．肿瘤心脏病学在中国的发展与展望[J]．中华心力衰竭和心肌病杂志，2018，2(3):187-189.
|
| [12] |
马作旺，张凯，李广平．肿瘤与心律失常的关系[J]．实用心电学杂志，2018，27(2):134-137.
|
| [13] |
彭毅，谭文勇．抗肿瘤治疗相关的心脏血管毒性：肿瘤心脏病学亟待跟进[J]．临床与病理杂志，2015，35(3):433-443.
|
| [14] |
赵睿，程蕾蕾．超声斑点追踪显像在肿瘤心脏病学中的应用[J]．心血管病学进展，2018，39(2):138-143.
|
| [15] |
王阿曼，夏云龙．大数据时代肿瘤心脏病学的机遇和挑战[J]．心血管病学进展，2018，39 (2):135-137.
|
| [16] |
Aleman BMP, Moser EC, Nuver J, et al. Cardiovascular disease after cancer therapy[J]．EJC Suppl，2014，12(1):18-28.
|
| [17] |
Abdel-Qadir H, Amir E, Thavendiranathan P．Prevention，detection，and management of chemotherapy-related cardiac dysfunction[J]．Can J Cardiol，2016，32(7):891-899.
|
| [18] |
Francis SA, Asnani A, Neilan T，et al.Optimizing cardio-oncology programs for cancer patients[J]．Future Oncol，2015，11(14):2011-2015.
|
| [19] |
Tarantini L, Massimo GM, Di Lenarda A，et al.ANMCO/AIOM/AICO consensus document on clinical and management pathways of cardio-oncology：executive summary[J]．Eur Heart J，2017，19(Suppl D):D370-D379.
|
| [20] |
Chang HM, OkwuosaTM, Scarabelli T，et al.Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management-Part 2[J]．J Am Coll Cardiol，2017，70(20):2552-2565.
|
| [21] |
李浩，孔令泉，吴凯南．乳腺肿瘤心脏病学的建立及多学科协作的意义[J]．中国临床新医学，2018，11(1):94-97.
|